Overview Pioglitazone vs. Placebo in Association With Pegylated Interferon and Ribavirin in HCV Patients With Insulin Resistance Status: Terminated Trial end date: 2012-07-06 Target enrollment: Participant gender: Summary The purpose of this study is to test whether the correction of insulin resistance with pioglitazone, will improve the response to antiviral treatment. Phase: Phase 3 Details Lead Sponsor: French National Agency for Research on AIDS and Viral HepatitisTreatments: Antiviral AgentsInsulinInterferonsPioglitazoneRibavirin